cetyltrimethylammonium ion has been researched along with Cancer of Prostate in 2 studies
Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L | 1 |
| Li, L | 1 |
| Zhang, L | 1 |
| Xing, S | 1 |
| Wang, T | 1 |
| Wang, YA | 1 |
| Wang, C | 1 |
| Su, Z | 1 |
| Wissing, MD | 1 |
| Mendonca, J | 1 |
| Kim, E | 2 |
| Shim, JS | 1 |
| Kaelber, NS | 1 |
| Kant, H | 1 |
| Hammers, H | 1 |
| Commes, T | 1 |
| Van Diest, PJ | 1 |
| Liu, JO | 1 |
| Kachhap, SK | 1 |
2 other studies available for cetyltrimethylammonium ion and Cancer of Prostate
| Article | Year |
|---|---|
Designed fabrication of unique eccentric mesoporous silica nanocluster-based core-shell nanostructures for pH-responsive drug delivery.
Topics: Acrylic Resins; Antineoplastic Agents; Cell Line, Tumor; Cetrimonium; Cetrimonium Compounds; Drug De | 2013 |
Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Cycle Proteins; Cell Growth Processes; Cell Li | 2013 |